Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
BioNTech SE Sponsored ADR (BNTX) had Income from Continuous Operations of $-1.29B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.25B |
|
$-1.29B |
|
$726.13M |
|
$2.52B |
|
$4.84B |
|
$-1.59B |
|
$400.63M |
|
$-1.19B |
|
$-1.19B |
|
$-1.29B |
|
|
Income from Continuous Operations |
$-1.29B |
$-1.29B |
|
$-1.29B |
|
$-1.59B |
|
$-1.16B |
|
241.70M |
|
241.70M |
|
$-5.32 |
|
$-5.32 |
|
| Balance Sheet Financials | |
$18.27B |
|
$1.22B |
|
$6.61B |
|
$24.88B |
|
$2.42B |
|
$243.48M |
|
$703.84M |
|
$3.13B |
|
$21.75B |
|
$19.52B |
|
$21.75B |
|
251.32M |
|
| Cash Flow Statement Financials | |
$515.92M |
|
$-2.79B |
|
$-59.85M |
|
$11.04B |
|
$8.68B |
|
$-2.36B |
|
$91.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.54 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
77.64% |
|
-48.95% |
|
-48.95% |
|
-35.61% |
|
-36.61% |
|
-39.59% |
|
$322.90M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
5.80 |
|
2.94 |
|
124.23 |
|
-5.91% |
|
-6.59% |
|
-5.17% |
|
-5.84% |
|
$86.54 |
|
$1.34 |
|
$2.13 |
|